Article
Erythroid Differentiation Enhances RNA Mis-Splicing in SF3B1-Mutant Myelodysplastic Syndromes with Ring Sideroblasts.
Cancer research - 16 Jan 2024
Moura Pedro L, Mortera-Blanco Teresa, Hofman Isabel J, Todisco Gabriele, Kretzschmar Warren W, Björklund Ann-Charlotte, Creignou Maria, Hagemann-Jensen Michael, Ziegenhain Christoph, Cabrerizo Granados David, Barbosa Indira, Walldin Gunilla, Jansson Monika, Ashley Neil, Mead Adam J, Lundin Vanessa, Dimitriou Marios, Yoshizato Tetsuichi, Woll Petter S, Ogawa Seishi, Sandberg Rickard, Jacobsen Sten Eirik W, Hellström-Lindberg Eva
Abstract excerpt
Myelodysplastic syndromes with ring sideroblasts (MDS-RS) commonly develop from hematopoietic stem cells (HSC) bearing mutations in the splicing factor SF3B1 (SF3B1mt). Direct studies into MDS-RS pathobiology have been limited by a lack of model systems that fully recapitulate erythroid biology and RS development and the inability to isolate viable human RS. Here, we combined successful direct RS isolation from...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
